Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Haffner

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|May 3, 2005
Insulin analoguesMichael C Haffner, Marcus P Kufner
European Urology|December 15, 2015
Shifting Paradigms for High-grade Prostatic Intraepithelial NeoplasiaMichael C Haffner, Christopher E Barbieri
European Urology|September 4, 2021
Divining Harm-Benefit Tradeoffs of Magnetic Resonance Imaging-targeted BiopsyRuth Etzioni, Michael C Haffner, Roman Gulati
Journal of Mammary Gland Biology and Neoplasia|August 11, 2006
Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancerMichael C Haffner, Chiara Berlato, Wolfgang Doppler
Clinics in Laboratory Medicine|May 31, 2024
Molecular Pathology of Prostate CancerIbrahim Kulac, Martine P Roudier, Michael C Haffner
Cell Reports. Medicine|March 4, 2022
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymesStephen R Plymate, Cynthia Sprenger, Michael C Haffner
Surgical Pathology Clinics|August 10, 2021
Molecular Pathology of Prostate CancerIbrahim Kulac, Martine P Roudier, Michael C Haffner
American Journal of Clinical and Experimental Urology|April 19, 2018
The structure of the nucleus in normal and neoplastic prostate cells: untangling the role of type 2 DNA topoisomerasesWilliam G Nelson, Michael C Haffner, Srinivasan Yegnasubramanian
Cancer Cell|July 12, 2011
Beefing up prostate cancer therapy with performance-enhancing (anti-) steroidsWilliam G Nelson, Michael C Haffner, Srinivasan Yegnasubramanian
European Urology Focus|July 21, 2017
The Role of Biomarkers and Genetics in the Diagnosis of Prostate CancerFiras Abdollah, Deepansh Dalela, Michael C Haffner, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|May 3, 2005
Insulin analoguesMichael C Haffner, Marcus P Kufner
European Urology|December 15, 2015
Shifting Paradigms for High-grade Prostatic Intraepithelial NeoplasiaMichael C Haffner, Christopher E Barbieri
European Urology|September 4, 2021
Divining Harm-Benefit Tradeoffs of Magnetic Resonance Imaging-targeted BiopsyRuth Etzioni, Michael C Haffner, Roman Gulati
Journal of Mammary Gland Biology and Neoplasia|August 11, 2006
Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancerMichael C Haffner, Chiara Berlato, Wolfgang Doppler
Clinics in Laboratory Medicine|May 31, 2024
Molecular Pathology of Prostate CancerIbrahim Kulac, Martine P Roudier, Michael C Haffner
Cell Reports. Medicine|March 4, 2022
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymesStephen R Plymate, Cynthia Sprenger, Michael C Haffner
Surgical Pathology Clinics|August 10, 2021
Molecular Pathology of Prostate CancerIbrahim Kulac, Martine P Roudier, Michael C Haffner
American Journal of Clinical and Experimental Urology|April 19, 2018
The structure of the nucleus in normal and neoplastic prostate cells: untangling the role of type 2 DNA topoisomerasesWilliam G Nelson, Michael C Haffner, Srinivasan Yegnasubramanian
Cancer Cell|July 12, 2011
Beefing up prostate cancer therapy with performance-enhancing (anti-) steroidsWilliam G Nelson, Michael C Haffner, Srinivasan Yegnasubramanian
European Urology Focus|July 21, 2017
The Role of Biomarkers and Genetics in the Diagnosis of Prostate CancerFiras Abdollah, Deepansh Dalela, Michael C Haffner, et al.
Pageof 17